Sfoglia per SSD
Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy
2021 M. Spreafico, M. Cafora, C. Bragato, D. Capitanio, F. Marasca, B. Bodega, C. De Palma, M. Mora, C. Gelfi, A. Marozzi, A. Pistocchi
Targeting Macrophages and Synoviocytes IntracellularMilieu to Augment Anti-Inflammatory Drug Potency
2022 V.M. Gouveia, L. Rizzello, B. Vidal, C. Nunes, A. Poma, C. Lopez-Vasquez, E. Scarpa, S. Brandner, A. Oliveira, J.E. Fonseca, S. Reis, G. Battaglia
Targeting mitochondrial dynamics to tackle duchenne muscular dystrophy progression
2023 S.R. Casati, O. Gjana, S. Zecchini, M. Giovarelli, E. Clementi, C. Perrotta, C. De Palma
Targeting mitochondrial dynamics to tackle Duchenne muscular dystrophy progression
2023 S.R. Casati, O. Gjana, S. Zecchini, M. Giovarelli, C. DE PALMA
Targeting mitochondrial dynamics to tackle Duchenne muscular dystrophy progression
2024 S.R. Casati, O. Gjana, S. Zecchini, M. Giovarelli, M. Caccia, S. Barozzi, S. Falcone, C. DE PALMA
Targeting mononuclear phagocytes for eradicating intracellular parasites
2017 L. Rizzello, J.D. Robertson, P.M. Elks, A. Poma, N. Daneshpour, T.K. Prajsnar, D. Evangelopoulos, J.O. Canseco, S. Yona, H.M. Marriott, D.H. Dockrell, S.J. Foster, B. De Geest, S. De Koker, T. Mchugh, S.A. Renshaw, G. Battaglia
Targeting Multiple Mitochondrial Processes by a Metabolic Modulator Prevents Sarcopenia and Cognitive Decline in SAMP8 Mice
2020 D. Brunetti, E. Bottani, A. Segala, S. Marchet, F. Rossi, F. Orlando, M. Malavolta, M.O. Carruba, C. Lamperti, M. Provinciali, E. Nisoli, A. Valerio
Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias
2012 F. Gardoni, C. Sgobio, V. Pendolino, P. Calabresi, M. Di Luca, B. Picconi
Targeting of neurotrophic factors, their receptors, and signaling pathways in the developmental neurotoxicity of organophosphates in vivo and in vitro
2008 T.A. Slotkin, F.J. Seidler, F. Fumagalli
Targeting PCSK9 for Hypercholesterolemia
2014 G.D. Norata, G. Tibolla, A.L. Catapano
Targeting Plk1 to chromosome arms and regulating chromosome compaction by the PICH ATPase
2008 M. Leng, D. Besusso, S.Y. Jung, Y. Wang, J. Qin
Targeting prokineticin system counteracts hypersensitivity, neuroinflammation and tissue damage in a mouse model of bortezomib induced peripheral neuropathy
2019 G. Moschetti, G. Amodeo, D. Maftei, R. Lattanzi, P. Procacci, P. Sartori, G. Balboni, V. Onnis, V. Conte, A. Panerai, P. Sacerdote, S. Franchi
TARGETING PROKINETICIN SYSTEM TO COUNTERACT EXPERIMENTAL CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY.
2019 G. Moschetti
Targeting the action of antidepressant drugs on second-messenger systems
1996 G. Racagni, M. Popoli, S. Mori, N. Brunello, J. Perez
Targeting the D3R-nAChR heteromeric complex for nicotine cessation
2023 V. Lallai, C. Matera, K. Bodinayake, C.M.L. Dallanoce, C. Fowler
Targeting the JNK pathway as a therapeutic protective strategy for nervous system diseases
2005 C. Bonny, T. Borsello, A. Zine
Targeting the Nrf2/Amyloid-Beta Liaison in Alzheimer's Disease: A Rational Approach
2017 E. Simoni, M.M. Serafini, R. Caporaso, C. Marchetti, M. Racchi, A. Minarini, M. Bartolini, C. Lanni, M. Rosini
The Tat-Aβ1-6A2V(D) peptide against AD synaptopathy
2017 L. Buccarello, T. Borsello
The TAT-JNK inhibitor peptide interferes with beta amyloid protein stability
2007 A. Colombo, M. Repici, M. Pesaresi, S. Santambrogio, G. Forloni, T. Borsello
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy
2008 B. Borroni, M. Malinverno, F. Gardoni, A. Alberici, L. Parnetti, E. Premi, U. Bonuccelli, M. Grassi, D. Perani, P. Calabresi, M. Di Luca, A. Padovani
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile